Positive 9-month follow-up data for NDV-01 showed a 92% overall response rate at any time in non-muscle invasive bladder cancer (NMIBC), with favorable overall safety Secured FDA alignment on key ...

In a world first, Lipsman and his team in Sunnybrook’s Hurvitz Brain Sciences Program non-invasively breached the blood-brain barrier using a focused ultrasound procedure guided by MRI. It allowed ...